ArticleBlood advances2021

Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2.

Satoshi Nishiwaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.